These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 844163)

  • 1. Determination of nonsuppressible insulin-like activity in human serum by a sensitive protein-binding assay.
    Zapf J; Kaufmann U; Eigenmann EJ; Froesch ER
    Clin Chem; 1977; 23(4):677-82. PubMed ID: 844163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels.
    Schalch DS; Heinrich UE; Koch JG; Johnson CJ; Schlueter RJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):664-71. PubMed ID: 755052
    [No Abstract]   [Full Text] [Related]  

  • 3. [Competitive protein-binding assay for somatomedins and their carrier protein (author's transl)].
    Binoux M; Lassarre C; Seurin D
    Ann Endocrinol (Paris); 1980; 41(1):67-9. PubMed ID: 7396401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels.
    Binoux M; Seurin D; Lassarre C; Gourmelen M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):453-62. PubMed ID: 6205015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification and characterization of somatomedin from sheep serum.
    Hossner KL; Davis SL; Powell C; Sasser RG
    Endocrinology; 1985 Apr; 116(4):1351-6. PubMed ID: 3971919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders.
    Zapf J; Morell B; Walter H; Laron Z; Froesch ER
    Acta Endocrinol (Copenh); 1980 Dec; 95(4):505-17. PubMed ID: 7006291
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSILA and foetal growth.
    Heinrich UE; Schalch DS; Jawadi MH; Johnson CJ
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):534-43. PubMed ID: 425788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of receptor assayable insulin-like activity in various diseases].
    Namba O; Hyodo T
    Nihon Naibunpi Gakkai Zasshi; 1983 Nov; 59(11):1714-28. PubMed ID: 6365608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsuppressible insulin-like activity in human serum. 3. Differentiation of two distinct molecules with nonsuppressible ILA.
    Jakob A; Hauri C; Froesch ER
    J Clin Invest; 1968 Dec; 47(12):2678-88. PubMed ID: 5725280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsuppressible insulin-like activity and somatomedin C levels in normal pregnant women, in pregnant women with gestational diabetes, and in umbilical cord blood of mature and premature infants.
    Samaan NA; Vassilopoulou-Sellin R; Schultz PN; Rivera ME; Held B
    Am J Obstet Gynecol; 1985 Oct; 153(4):457-61. PubMed ID: 4050920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction.
    Herington AC; Kuffer AD
    Endocrinology; 1981 Nov; 109(5):1634-40. PubMed ID: 7297496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-suppressible insulin-like activity in Laron's syndrome.
    Kastrup KW; Zapf J
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):414-20. PubMed ID: 425784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay for non-suppressible insulin-like activity.
    Reber K; Liske R
    Horm Res; 1976; 7(4-5):201-13. PubMed ID: 1017791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
    Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.
    Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of the IGF (insulin-like growth factors or somatomedins) competitive binding assay in the study of growth disorders in children (results for 124 observations) (author's transl)].
    Gourmelen M; Girard F; Binoux M
    Arch Fr Pediatr; 1980; 37 Suppl 2():XXXIII-XXXVIII. PubMed ID: 7447617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.